TipRanks
Aurinia Pharmaceuticals (AUPH)
NASDAQ:AUPH
US Market
AUPH
Aurinia Pharmaceuticals
RESEARCH TOOLSreports
Want to see AUPH full AI Analyst Report?

Aurinia Pharmaceuticals (AUPH) Ratios

2,169 Followers

Aurinia Pharmaceuticals Ratios

AUPH's free cash flow for Q2 2026 was $0.92. For the 2026 fiscal year, AUPH's free cash flow was decreased by $ and operating cash flow was $0.60. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 5.42 5.25 4.57 5.50 9.60
Quick Ratio
 4.97 4.76 4.17 4.99 9.06
Cash Ratio
 1.80 0.86 0.85 0.63 2.04
Solvency Ratio
 1.88 1.74 0.15 -0.39 -1.61
Operating Cash Flow Ratio
 1.74 1.45 0.45 -0.43 -1.72
Short-Term Operating Cash Flow Coverage
 0.00 0.00 0.00 0.00 0.00
Net Current Asset Value
$ 363.93M$ 321.71M$ 273.43M$ 254.69M$ 377.11M
Leverage Ratios
Debt-to-Assets Ratio
 0.08 0.10 0.14 0.18 0.02
Debt-to-Equity Ratio
 0.10 0.13 0.21 0.26 0.02
Debt-to-Capital Ratio
 0.09 0.11 0.17 0.21 0.02
Long-Term Debt-to-Capital Ratio
 0.00 0.00 0.00 0.00 0.00
Financial Leverage Ratio
 1.29 1.29 1.46 1.45 1.16
Debt Service Coverage Ratio
 40.35 69.47 6.21 -22.92 0.00
Interest Coverage Ratio
 17.79 24.23 -0.97 -33.04 0.00
Debt to Market Cap
 0.00 0.00 0.00 0.00 0.00
Interest Debt Per Share
 0.53 0.59 0.59 0.70 0.06
Net Debt to EBITDA
 -0.63 -0.04 -0.13 -0.77 0.83
Profitability Margins
Gross Profit Margin
90.36%88.46%87.99%91.94%95.77%
EBIT Margin
54.20%41.86%5.22%-42.56%-79.35%
EBITDA Margin
60.42%45.14%13.49%-35.92%-77.33%
Operating Profit Margin
48.39%37.06%-1.99%-52.24%-83.17%
Pretax Profit Margin
51.48%40.33%3.17%-44.14%-79.35%
Net Profit Margin
100.84%101.47%2.45%-44.45%-80.71%
Continuous Operations Profit Margin
100.84%101.47%2.45%-44.45%-80.71%
Net Income Per EBT
195.88%251.59%77.23%100.71%101.72%
EBT Per EBIT
106.38%108.81%-158.91%84.49%95.41%
Return on Assets (ROA)
39.65%38.21%1.04%-14.24%-22.97%
Return on Equity (ROE)
59.00%49.40%1.52%-20.64%-26.68%
Return on Capital Employed (ROCE)
21.77%15.95%-1.03%-19.47%-26.24%
Return on Invested Capital (ROIC)
21.27%15.53%-0.77%-18.85%-26.19%
Return on Tangible Assets
39.82%38.40%1.05%-14.37%-23.29%
Earnings Yield
14.97%13.40%0.45%-6.06%-17.65%
Efficiency Ratios
Receivables Turnover
 7.57 6.83 6.43 7.29 9.94
Payables Turnover
 17.31 9.86 5.45 3.27 1.83
Inventory Turnover
 0.67 0.71 0.72 0.36 0.23
Fixed Asset Turnover
 4.55 3.56 2.38 1.51 15.66
Asset Turnover
 0.39 0.38 0.43 0.32 0.28
Working Capital Turnover Ratio
 0.75 0.76 0.68 0.47 0.31
Cash Conversion Cycle
 575.80 526.98 496.58 962.80 1.43K
Days of Sales Outstanding
 48.20 53.46 56.73 50.10 36.72
Days of Inventory Outstanding
 548.68 510.54 506.88 1.02K 1.60K
Days of Payables Outstanding
 21.08 37.02 67.02 111.63 198.93
Operating Cycle
 596.88 564.00 563.60 1.07K 1.63K
Cash Flow Ratios
Operating Cash Flow Per Share
 1.34 1.01 0.31 -0.23 -0.56
Free Cash Flow Per Share
 1.33 1.01 0.31 -0.24 -0.56
CapEx Per Share
 <0.01 <0.01 <0.01 <0.01 <0.01
Free Cash Flow to Operating Cash Flow
 1.00 1.00 0.99 1.02 1.00
Dividend Paid and CapEx Coverage Ratio
 1.00K 538.33 157.96 -46.60 -272.36
Capital Expenditure Coverage Ratio
 1.00K 538.33 157.96 -46.60 -272.36
Operating Cash Flow Coverage Ratio
 2.88 1.81 0.56 -0.34 -9.83
Operating Cash Flow to Sales Ratio
 0.56 0.48 0.19 -0.19 -0.59
Free Cash Flow Yield
8.37%6.32%3.43%-2.65%-13.02%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 6.83 7.45 224.50 -16.50 -5.67
Price-to-Sales (P/S) Ratio
 6.66 7.57 5.46 7.34 4.57
Price-to-Book (P/B) Ratio
 3.41 3.69 3.40 3.41 1.51
Price-to-Free Cash Flow (P/FCF) Ratio
 11.95 15.83 29.13 -37.67 -7.68
Price-to-Operating Cash Flow Ratio
 12.08 15.80 28.94 -38.48 -7.71
Price-to-Earnings Growth (PEG) Ratio
 0.02 <0.01 -2.09 0.57 0.12
Price-to-Fair Value
 3.41 3.69 3.40 3.41 1.51
Enterprise Value Multiple
 10.39 16.73 40.36 -21.20 -5.08
Enterprise Value
 1.95B 2.14B 1.28B 1.34B 526.99M
EV to EBITDA
 10.39 16.73 40.36 -21.20 -5.08
EV to Sales
 6.28 7.55 5.45 7.61 3.93
EV to Free Cash Flow
 11.26 15.79 29.03 -39.10 -6.60
EV to Operating Cash Flow
 11.25 15.76 28.85 -39.94 -6.63
Tangible Book Value Per Share
 4.70 4.30 2.61 2.60 2.81
Shareholders’ Equity Per Share
 4.73 4.33 2.64 2.64 2.86
Tax and Other Ratios
Effective Tax Rate
 -0.96 -1.52 0.23 >-0.01 -0.02
Revenue Per Share
 2.39 2.11 1.64 1.23 0.94
Net Income Per Share
 2.41 2.14 0.04 -0.54 -0.76
Tax Burden
 1.96 2.52 0.77 1.01 1.02
Interest Burden
 0.95 0.96 0.61 1.04 1.00
Research & Development to Revenue
 0.13 0.11 0.09 0.28 0.34
SG&A to Revenue
 0.32 0.36 0.73 1.11 1.47
Stock-Based Compensation to Revenue
 0.03 0.05 0.13 0.26 0.24
Income Quality
 0.55 0.47 7.72 0.43 0.74
Currency in USD